Shenzhen Weilinfeng Electronics Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Weilinfeng Electronics Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include LOTTOO. The owner is based in Longhua Dist.,Shenzhen.

Unit 2606, Unit B, Building 1, Phase 1,

Xingfu City Runyuan, Longhua St.,

Longhua Dist.,Shenzhen 518000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LOTTOO
LOTTOO
Registered 2020

Trademark Classifications

Shenzhen Weilinfeng Electronics Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhen Weilinfeng Electronics Co., Ltd. have?

Shenzhen Weilinfeng Electronics Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Weilinfeng Electronics Co., Ltd. file in?

Shenzhen Weilinfeng Electronics Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Shenzhen Weilinfeng Electronics Co., Ltd.'s most well-known trademarks?

Shenzhen Weilinfeng Electronics Co., Ltd.'s registered trademark portfolio includes well-known marks such as LOTTOO. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Weilinfeng Electronics Co., Ltd.'s trademark registration success rate?

Shenzhen Weilinfeng Electronics Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.